SARS-CoV-2-IN-45
SARS-CoV-2-IN-45 (Compound 8p) is a SARS-CoV-2 inhibitor. SARS-CoV-2-IN-45 inhibits SARS-CoV-2 replication in Calu-3 cell with an EC50 of 0.5 μM, and has no evident cytotoxic effect[1].
Product Specifications
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-in-45.html
Solubility
10 mM in DMSO
Smiles
O=C1C2=CC=C(OCOC)C=C2O/C1=C\C3=CC(OCOC)=C(OC)C=C3
Molecular Formula
C20H20O7
Molecular Weight
372.37
References & Citations
[1]Caleffi GS, et al. Aurones: A Promising Scaffold to Inhibit SARS-CoV-2 Replication. J Nat Prod. 2023 Jun 23;86 (6) :1536-1549.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15110950 1 Vial
Lentiviral human RAD9A shRNA (UAS) - Lentiviral human RAD9A shRNA (UAS, GFP) plasmid
Ask
View Details 
